INND Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.08
Previous CloseN/A
Volume1.45M
Average Volume (3M)230.50K
Market Cap
$39.40K
Enterprise Value$1.77M
Total Cash (Recent Filing)$2.70K
Total Debt (Recent Filing)$773.32K
Price to Earnings (P/E)―
Beta-37.19
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding393,962,740
10 Day Avg. Volume186,808
30 Day Avg. Volume230,502
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)<0.01
Price to Sales (P/S)5.28
P/FCF Ratio-1.09
Enterprise Value/Market Cap44.82
Enterprise Value/Revenue29.08
Enterprise Value/Gross Profit-45.50
Enterprise Value/Ebitda-6.56
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
INND FAQ
What was Innerscope Hearing Technologies’s price range in the past 12 months?
Innerscope Hearing Technologies lowest stock price was <$0.01 and its highest was $0.08 in the past 12 months.
What is Innerscope Hearing Technologies’s market cap?
Innerscope Hearing Technologies’s market cap is $39.40K.
When is Innerscope Hearing Technologies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Innerscope Hearing Technologies’s earnings last quarter?
Innerscope Hearing Technologies released its earnings results on Nov 16, 2022. The company reported $1.225 earnings per share for the quarter, beating the consensus estimate of N/A by $1.225.
Is Innerscope Hearing Technologies overvalued?
According to Wall Street analysts Innerscope Hearing Technologies’s price is currently Overvalued.
Does Innerscope Hearing Technologies pay dividends?
Innerscope Hearing Technologies does not currently pay dividends.
What is Innerscope Hearing Technologies’s EPS estimate?
Innerscope Hearing Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Innerscope Hearing Technologies have?
Innerscope Hearing Technologies has 393,962,740 shares outstanding.
What happened to Innerscope Hearing Technologies’s price movement after its last earnings report?
Innerscope Hearing Technologies reported an EPS of $1.225 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Innerscope Hearing Technologies?
Currently, no hedge funds are holding shares in INND
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Innerscope Hearing Technologies
InnerScope Hearing Technologies, Inc. specializes in delivering a variety of hearing solutions, primarily supplying the retail hearing aid community with its array of hearing aids and personal sound amplification devices, available in both hearable and wearable forms. The company's operations encompass the manufacturing and direct-to-consumer distribution and sales of these devices. Beyond hardware, InnerScope also offers a suite of related products and services, which include hearing-related therapeutic treatments, physician-developed dietary supplements aimed at supporting hearing health, and a unique CBD oil specifically formulated for managing tinnitus. Expanding its comprehensive approach, InnerScope manages and operates eleven audiological and retail hearing device clinics. Additionally, it provides a business-to-business (B2B) software-as-a-service (SaaS) platform for patient management. Founded in 2012 as Innerscope Advertising Agency, Inc., the company officially adopted its current name, InnerScope Hearing Technologies, Inc., in August 2017, and its corporate headquarters are located in Roseville, California.
GlucoTrack
―
Innovative Eyewear, Inc.
―
Nexalin Technology, Inc.
―
Mobile-health Network Solutions Class A
―
20/20 Biolabs, Inc.
―